UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

The Lancet infectious diseases, 2019-03, Vol.19 (3), p.253-264

2019

Link zum Volltext

Verfügbarkeit prüfen

Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load

PLoS computational biology, 2023-01, Vol.19 (1), p.e1010756-e1010756

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with D-dimer levels in HIV-infected individuals

PloS one, 2014-03, Vol.9 (3), p.e90978-e90978

2014

Link zum Volltext

Verfügbarkeit prüfen

Telemedicine in HIV health care during the COVID-19 pandemic: An implementation research study in Buenos Aires, Argentina

HIV medicine, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America

PloS one, 2015-12, Vol.10 (12), p.e0145380-e0145380

2015

Link zum Volltext

Verfügbarkeit prüfen

Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy–Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial

The Journal of infectious diseases, 2019-09, Vol.220 (8), p.1325-1334

2019

Link zum Volltext

Verfügbarkeit prüfen

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Journal of hepatology, 2013-08, Vol.59 (2), p.213-220

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3

PloS one, 2017-05, Vol.12 (5), p.e0176009-e0176009

2017

Link zum Volltext

Verfügbarkeit prüfen

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

BMC infectious diseases, 2018-04, Vol.18 (1), p.191-191, Article 191

2018

Link zum Volltext

Verfügbarkeit prüfen

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

HIV research & clinical practice, 2022-07, Vol.23 (1), p.37-46

2022

Link zum Volltext

Verfügbarkeit prüfen

When should antiretroviral therapy for HIV be started?

BMJ (British Medical Journal), 2007-01, Vol.334 (7584), p.76-78

International edition, 2007

Link zum Volltext

Verfügbarkeit prüfen

Repeat pregnancy in women with HIV infection in Latin America and the Caribbean

AIDS care, 2015-10, Vol.27 (10), p.1289-1297

2015

Link zum Volltext

Verfügbarkeit prüfen

Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study

Pediatrics (Evanston), 2007-03, Vol.119 (3), p.e694

2007

Link zum Volltext

Verfügbarkeit prüfen

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

The New England journal of medicine, 2021-08, Vol.385 (7), p.595-608

2021

Link zum Volltext

Verfügbarkeit prüfen

Late diagnosis of HIV infection in asymptomatic patients

Medicina (Buenos Aires), 2016-01, Vol.76 (5), p.273-278

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study

International journal of STD & AIDS, 2016-02, Vol.27 (2), p.118-126

2016

Link zum Volltext

Verfügbarkeit prüfen

HLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populations

PloS one, 2008-10, Vol.3 (10), p.e3429-e3429

2008

Link zum Volltext

Verfügbarkeit prüfen

TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality

BioMed research international, 2013-01, Vol.2013, p.373601-9

2013

Link zum Volltext

Verfügbarkeit prüfen

HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina

AIDS research and human retroviruses, 2007-10, Vol.23 (10), p.1201

2007

Link zum Volltext

Verfügbarkeit prüfen

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study

BMC infectious diseases, 2012-09, Vol.12 (1), p.229-229, Article 229

2012

Link zum Volltext

Verfügbarkeit prüfen

Detection of HIV-1 dual infections in highly exposed treated patients

Virology journal, 2011-08, Vol.8 (1), p.392-392, Article 392

2011

Link zum Volltext

Verfügbarkeit prüfen

Utility of Mobile Communication Devices as a Tool to Improve Adherence to Antiretroviral Treatment in HIV-infected Children and Young Adults in Argentina

The Pediatric infectious disease journal, 2018-04, Vol.37 (4), p.345-348

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

Antiviral therapy, 2022-04, Vol.27 (2), p.135965352210774

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

The Lancet (British edition), 2014-04, Vol.383 (9927), p.1474-1482

Anon

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study

The Lancet infectious diseases, 2015-07, Vol.15 (7), p.793-802

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

ThemaHiv

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load

Factors associated with D-dimer levels in HIV-infected individuals

Telemedicine in HIV health care during the COVID-19 pandemic: An implementation research study in Buenos Aires, Argentina

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America

Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy–Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

When should antiretroviral therapy for HIV be started?

Repeat pregnancy in women with HIV infection in Latin America and the Caribbean

Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Late diagnosis of HIV infection in asymptomatic patients

Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study

HLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populations

TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality

HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study

Detection of HIV-1 dual infections in highly exposed treated patients

Utility of Mobile Communication Devices as a Tool to Improve Adherence to Antiretroviral Treatment in HIV-infected Children and Young Adults in Argentina

Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study

Aktive Filter

Suchergebnisse filtern